About 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile
4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile (PubChem CID 23390015) has the molecular formula C28H29BrFN5O5S
and a molecular weight of 646.54 g/mol. Its IUPAC name is 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile.
Molecular Properties
| Compound Name | 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile |
| PubChem CID | 23390015 |
| Molecular Formula | C28H29BrFN5O5S |
| Molecular Weight | 646.54 g/mol |
| Exact Mass | 645.11 |
| IUPAC Name | 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile |
| SMILES | CS(=O)(=O)CCC1CN(c2cc(Br)cc(OCCF)c2)C(=O)CN1C(Cc1ccc(C#N)cc1)C(=O)c1cnc[nH]1 |
| InChI | InChI=1S/C28H29BrFN5O5S/c1-41(38,39)9-6-22-16-35(23-11-21(29)12-24(13-23)40-8-7-30)27(36)17-34(22)26(28(37)25-15-32-18-33-25)10-19-2-4-20(14-31)5-3-19/h2-5,11-13,15,18,22,26H,6-10,16-17H2,1H3,(H,32,33) |
| InChIKey | VUOCQOVFUCFLBM-UHFFFAOYSA-N |
| XLogP | 3.34 |
| TPSA | 136.46 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 646.54 |
| LogP ≤ 5 | 3.34 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile?
The IUPAC name of 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile (CID 23390015) is 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile.
What is the SMILES notation for 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile?
The canonical SMILES for 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile is CS(=O)(=O)CCC1CN(c2cc(Br)cc(OCCF)c2)C(=O)CN1C(Cc1ccc(C#N)cc1)C(=O)c1cnc[nH]1.
What is the InChIKey of 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile?
The InChIKey is VUOCQOVFUCFLBM-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H29BrFN5O5S/c1-41(38,39)9-6-22-16-35(23-11-21(29)12-24(13-23)40-8-7-30)27(36)17-34(22)26(28(37)25-15-32-18-33-25)10-19-2-4-20(14-31)5-3-19/h2-5,11-13,15,18,22,26H,6-10,16-17H2,1H3,(H,32,33).
What are the key properties of 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile?
4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile has a molecular weight of 646.54 g/mol, XLogP of 3.34, 12 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(2S)-2-[4-[3-bromo-5-(2-fluoroethoxy)phenyl]-2-(2-methylsulfonylethyl)-5-oxopiperazin-1-yl]-3-(1H-imidazol-5-yl)-3-oxopropyl]benzonitrile is sourced from PubChem (CID 23390015), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).